We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

58 hedge funds and large institutions have $3.12M invested in T2 Biosystems, Inc in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $40K | Put options by funds: $20K

13% less funds holding

Funds holding: 6758 (-9)

50% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 12

61% less capital invested

Capital invested by funds: $8.02M → $3.12M (-$4.9M)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
58
Holders Change
-9
Holders Change %
-13.43%
% of All Funds
0.98%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
6
Reduced
12
Closed
10
Calls
$40K
Puts
$20K
Net Calls
+$20K
Net Calls Change
-$49K

TTOO Hedge Fund Activity: Q2 2022 in Review

58 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2022, worth a combined $3.12M — down 61% from $8.02M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TTOO and 3 opened new positions — a net loss of 7 holders — while 12 trimmed existing stakes and 6 added.

The largest buyer was Vanguard Group, adding an estimated $1.2M. The largest seller was BlackRock, cutting an estimated $104K.

  • 58 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2022, down from 67 in Q1 2022.
  • Funds reported $3.12M of T2 Biosystems, Inc stock for Q2 2022, down 61% quarter-over-quarter.
  • 3 funds opened new T2 Biosystems, Inc positions in Q2 2022 and 10 closed out, a net change of -7 holders.
  • The largest T2 Biosystems, Inc buyer in Q2 2022 was Vanguard Group, an estimated $1.2M added.
  • The largest T2 Biosystems, Inc seller in Q2 2022 was BlackRock, an estimated $104K sold.

Based on aggregated 13F filings for Q2 2022.